Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Milestone ScientificMLSS -10.47%37 Equity-to-Asset is 0.42 as of Jun. 2026, which is 30% below its 10-year median of 0.60. GuruFocus rates MLSS with a GF Score™ of 37/100 and a GF Value™ of $0.60 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Milestone Scientific ranks worse than 74.74% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Milestone Scientific's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $3.47 Mil. Milestone Scientific's Total Assets for the quarter that ended in Jun. 2026 was $8.35 Mil.
Therefore, Milestone Scientific's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.42.
The historical rank and industry rank for Milestone Scientific's Equity-to-Asset or its related term are showing as below:
MLSS'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.22 Med: 0.6 Max: 0.85
Current: 0.42
During the past 13 years, the highest Equity to Asset Ratio of Milestone Scientific was 0.85. The lowest was -0.22. And the median was 0.60.
MLSS's Equity-to-Asset is ranked worse than 74.74% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs MLSS: 0.42
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Milestone Scientific Equity-to-Asset Related Terms
Milestone Scientific Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Milestone Scientific's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MLSS vs NEPH, HBIO, POCI: Equity-to-Asset Comparison
For the Medical Instruments & Supplies subindustry, Milestone Scientific's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Milestone Scientific Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Milestone Scientific's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Milestone Scientific's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Milestone Scientific's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Milestone Scientific (MLSS) has a Equity-to-Asset of 0.42 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Milestone Scientific and its competitors. This is 30% below median its historical median of 0.60. According to the industry distribution chart, Milestone Scientific ranks #636 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 74.7%.
Is Milestone Scientific's Equity-to-Asset too high?
Milestone Scientific's current Equity-to-Asset of 0.42 is 30% below median its 10-year median of 0.60. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Milestone Scientific's value of 0.42 is 34.4% below this industry median. Based on the distribution chart, Milestone Scientific ranks #636 out of 851 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Milestone Scientific has a GF Score™ of 37/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Milestone Scientific's Equity-to-Asset compare to NEPH and HBIO?
According to the Medical Devices & Instruments industry distribution chart, Milestone Scientific ranks #636 out of 851 companies for Equity-to-Asset. This places Milestone Scientific in the lower half of its industry. The industry median Equity-to-Asset is 0.64. Milestone Scientific's value of 0.42 is 34.4% below this benchmark. While the company's 10-year median is 0.60 vs. the industry median of 0.64, Milestone Scientific has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Milestone Scientific's current Equity-to-Asset of 0.42 is 34.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Milestone Scientific and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Milestone Scientific's current Equity-to-Asset is 0.42, which is 30% below median its own 10-year median of 0.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Milestone Scientific stock overvalued right now?
Based on GuruFocus' analysis, Milestone Scientific (MLSS) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.60, compared to a current price of $0.50 — trading 17.5% below its estimated fair value. The current Equity-to-Asset is 0.42, which is 30% below median its 10-year median of 0.60 and 34.4% below the Medical Devices & Instruments industry median of 0.64. Milestone Scientific's overall GF Score™ is 37/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Milestone Scientific (MLSS), the current Equity-to-Asset is 0.42 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Milestone Scientific (MLSS) Overvalued in 2026?
Based on GuruFocus' analysis, Milestone Scientific stock appears to be undervalued.
The current stock price of $0.50 is trading 17.5% below its estimated GF Value™ of $0.60.
GuruFocus considers Milestone Scientific to be Modestly Undervalued.
Key valuation signals for MLSS:
Equity-to-Asset: 0.42 (30% below median its 10-year median of 0.60)
GF Value™: $0.60 vs. price of $0.50 (17.5% below fair value)
Industry Position: 34.4% below the Medical Devices & Instruments median (#636 of 851)
No single metric tells the full story. See the MLSS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.
37GF Score
Get the complete analysis for MLSS
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLSS has been successfully added to your 
